New developments in the pharmacotherapy of cocaine dependence;Neue entwicklungen in der pharmakotherapie der kokainabhängigkeit

Nervenarzt

Volumn 77, Issue 9, 2006, Pages 1064-1070

  Wiesbeck, G A ^a   Dursteler MacFarland K ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Active immunisation; Cocaine dependence; Disulfiram; Methylphenidate; Selegiline; Topiramate; Vigabatrin

Indexed keywords

BACLOFEN; COCAINE; DISULFIRAM; METHYLPHENIDATE; MODAFINIL; SELEGILINE; TIAGABINE; TOPIRAMATE; VIGABATRIN;

BEHAVIOR THERAPY; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; HUMAN; IMMUNIZATION; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SWITZERLAND; TREATMENT INDICATION; UNITED STATES;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; HUMANS; IMMUNIZATION, PASSIVE; PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VACCINATION;

EID: 33749508432     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-005-2044-0     Document Type: Review

References (61)

1. Baird TJ, Deng SX, Landry DW (2000) Natural and artificial enzymes against cocaine. I: monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. J Pharmacol Exp Ther 295: 1127-1134
2. Bartzokis G, Beckson M, Newton T et al. (1999) Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria. Neuropsychopharmacology 20: 582-590
3. Basmadjian GP, Singh S, Sastrodjojo B (1995) Generation of polyclonal catalytic antibodies against cocaine using transition state analogs of cocaine conjugated to diphtheria toxoid. Chem Pharm Bull (Tokyo) 43: 1902-1911
4. Bonese KF, Wainer BH, Fitch FW et al. (1974) Changes in heroin self-administration by a rhesus monkey after morphine immunisation. Nature 252: 708-710
5. Brodie JD, Figueros E, Dewey SL (2003) Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA. Synapse 50: 261-265
6. Caroldi S, DeParis P (1995) Comparative effects of two dithiocarbamates disulfiram and thiram on adrenal catecholamine content and on plasma dopamine β-hydroxylase activity. Arch Toxicol 69: 690-693
7. Carroll K, Ziedonis D, O'Malley S et al. (1993) Pharmacologic interventions for alcohol- and cocaine-abusing individuals. A pilot study of disulfiram and naltrexone. Am J Addict 2: 77-79
8. Carroll KM, Fenton LR, Ball SA et al. (2004) Efficacy of disulfiram and cognitive behaviour therapy in cocain-dependent outpatients. Arch Gen Psychiatry 61: 264-272
9. Carroll KM, Nich C, Ball SA et al. (1998) Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 93: 713-728
10. Cashman JR, Berkman CE, Underiner GE (2000) Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure. J Pharmacol Exp Ther 293: 952-961
11. Dackis CA, Lynch KG, Yu E et al. (2003) Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend 70: 29-37
12. Dackis CA, Kampman KM, Lynch KG et al. (2005) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30: 205-211
13. Drogen- und Suchtbericht (2005) Drogen- und Suchtbericht 2005. http://www.bmgs.bund.de/ download/broschueren/A601-05.pdf
14. Europäische Beobachtungsstelle für Drogen und Drogensucht (2003) Jahresbericht 2003: Stand der Drogenproblematik in der Europäischen Union und in Norwegen. http://anualreport.emcd-da. eu.int. Amt für amtliche Veröffentlichungen der Europäischen Gemeinschaften, Luxemburg
15. Fadda P, Scherma M, Fresu A et al. (2003) Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat. Synapse 50: 1-6
16. Foltin RW, Fischman MW (1998) Effects of "binge" use of intravenous cocaine in methadone-maintained individuals. Addiction 93: 825-836
17. Fox BS, Kantak KM, Edwards MA et al. (1996) Efficacy of a therapeutic cocaine vaccine in rodent models. Nat Med 2: 1129-1132
18. Gawin FH, Riordan C, Kleber H (1985) Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report. Am J Drug Alcohol Abuse 11: 193-197
19. George TP, Chawarski MC, Pakes J (2000) Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biol Psychiatry 47: 1080-1086
20. Goldstein M, Anagoste B, Lauber E (1964) Inhibition of dopamine β-hydroxylase by disulfiram. Life Sci 3: 763-767
21. Grabowski J, Roache J, Schmitz J et al. (1997) Replacement medication for cocaine dependence: methylphenidate. J Clin Psychopharmacol 17: 485-488
22. Gonzales G, Sevarine K, Sofuoglu M et al. (2003) Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction 98: 1625-1632
23. Hadorn DC, Baker D, Hodges JS et al. (1996) Rating the quality of evidence for clinical practice guideline. J Clin Epidemiol 49: 749-754
24. Hall FS, Sora I, Drgonova J et al. (2004) Molecular mechanisms underlying the rewarding effects of cocaine. Ann N Y Acad Sci 1025: 47-56
25. Hameedi FA, Rosen MI, McCance-Katz EF et al. (1995) Behavioral, physiologic and pharmacologic ineraction of cocaine and disulfiram in humans. Biol Psychiatry 37: 560-563
26. Hearn WL, Flynn DD, Hime GW et al. (1991) Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. J Neurochem 56: 698-701
27. Higgins ST, Budney AJ, Bickel WK et al. (1993) Disulfiram therapy in patients abusing cocaine and alcohol. Am J Psychiatry 150: 675-676
28. Honjo T, Netter KJ (1969) Inhibition of drug demethylation by disulfiram in vivo and in vitrol. Biochem Pharmacol 18: 2681-2683
29. Houtsmuller EJ, Notes LD, Newton T et al. (2004) Transdermal selegiline and intravenous cocaine: safety and interactions. Psychopharmacology (Berl) 172: 31-40
30. Izenwasser S (2004) The role of the dopamine transporter in cocaine abuse. Neurotox Res 6: 379-383
31. Kampman KM, Pettinati H, Lynch KG et al. (2004) A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend 75: 233-240
32. Kantak KN, Collins SL, Lipman EG et al. (2000) Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration mode. Psychopharmacology (Berl) 148: 251-262
33. Kosten TR, Rosen M, Bond J et al. (2002) Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine 20: 1196-1204
34. Kuwahata T, Ishimatsu M, Kidani Y et al. (2002) Effects of methylphenidate on the inhibitory postsynaptic potential in rat locus coeruleus neurons. Kurume Med J 49: 185-190
35. Landry DW, Zhao K, Yang GX et al. (1993) Antibody-catalysed degradation of cocaine. Science 259: 1899-1901
36. Leri F, Bruneau J, Stewart J (2003) Understanding polydrug use: review of heroin and cocaine co-use. Addiction 98: 7-22
37. Lile JA, Stoops WW, Allen TS et al. (2004) Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans. Psychopharmacology (Berl) 171: 441-449
38. Lima MS, Reisser AAP, Soares BGO et al. (2002) Pharmacological treatment of cocaine dependence: a systematic review. Addiction 97: 931-949
39. Ling W, Shoptaw S, Majewska D (1998) Baclofen as a cocaine anti-craving medication: a preliminary clinical study. Neuropsychopharmacology 18: 403-404
40. Maffli E, Kuntsche S, Delgrande JM et al. (2003) Ambulante Suchtberatung 2001-Statistik der ambulanten Behandlung und Betreuung im Alkoholund Drogenbereich. Bundesamt für Statistik (BFS), Neuchatel
41. McCance-Katz EF, Kosten TR, Jatlow P (1998) Chronic disulfiram treatment effects on intranasal cocaine administration-initial results. Biol Psychiatry 43: 540-543
42. McCance-Katz EF, Kosten TR, Jatlow P (1998) Concurrent use of cocaine and alcohol is mor potent and potentially more toxic than use of either alone - a multiple-dose study. Biol Psychiatry 44: 250-259
43. McCance-Katz EF, Kosten TR, Jatlow P (1998) Disulfiram effects on acute cocaine administration. Drug Alcohol Depend 52: 27-39
44. Morell V (1993) Enzyme may blunt cocaine's action. Science 259: 1828
45. Narring F, Tschumper A, Inderwildi Bonivento L (2002) Gesundheit und Lebensstil 16- bis 20 Jähriger in der Schweiz. SMASH 2002: Swiss multicenter adolescent study on health 2002. Institut universitaire de médecine sociale et préventive, Lausanne
46. Newton T, Kalechstein A, Beckson M et al. (1999) Effects of selegiline pre-treatment on response to experimental cocaine administration. Psychiatry Res 87: 101-106
47. Nich C, McCance-Katz EF, Petrakis IL et al. (2004) Sex differences in cocaine-dependent individuals' response to disulfiram treatment. Addict Behav 29: 1123-1128
48. NIDA (2005) Topiramate shows promise in cocaine addiction. NIDA Notes 19: 1-6
49. Parran TV, Jasinski DR (1991) Intravenous methylphenidate abuse: prototype for prescription drug abuse. Arch Intern Med 151: 781-783
50. Ritz MC, Lamb RJ, Goldberg SR et al. (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223
51. Roache J, Grabowski J, Schmitz J et al. (2000) Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment. J Clin Psychopharmacol 20: 61-68
52. Rocha BA, Fumagalli F, Gainetdinov RR et al. (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1: 132-137
53. Scheid R, Schindler E, Biniek R (1999) Kokaininduzierte akute ZNS-Erkrankungen. Nervenarzt 70: 315-321
54. Schiffer WK, Marsteller D, Dewey SL (2003) Sub-chronic gamma-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine. Psychopharmacology (Berl) 168: 339-343
55. Shaffer HJ, Eber GB (2002) Temporal progression of cocaine dependence symptoms in the US National Comorbidity Survey. Addiction 97: 543-554
56. Shoptaw S, Yank X, Rotheram-Fuller EJ et al. (2003) Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. J Clin Psychiatry 64: 1440-1448
57. Somoza EC, Winhusen TM, Rotrosen JP et al. (2004) An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. J Addict Dis 23: 77-92
58. Volkow ND, Ding YS, Fowler JS et al. (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52: 456-463
59. Volkow ND, Wang GJ, Fowler JS et al. (1999) Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high". J Pharmacol Exp Ther 288: 14-20
60. Volkow ND, Wang GJ, Fowler JS et al. (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155: 1325-1331
61. Yang G, Chun J, Arakawa-Uramoto H (1996) Anticocaine catalytic antibodies: a synthetic approach to improved antibody diversity. J Am Chem Soc 118: 5881-5890